Elixirgen Therapeutics

Elixirgen Therapeutics, Inc. is a Baltimore-based biotechnology company co-founded by Akihiro Ko and Minoru Ko, M.D., Ph.D., in 2017. The company focuses on curing human diseases through innovations in stem cell biology. Its team of experienced researchers possesses a wide range of expertise, enabling the development of therapies for genetic disorders and vaccines using both basic and translational research approaches.